|
BIIB
|
Biogen Idec Inc.
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
US
|
NASDAQ
|
|
DICE
|
DICE Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
US
|
NASDAQ
|
|
GLTO
|
Galecto, Inc.
|
US
|
NASDAQ
|
|
LMNL
|
Liminal BioSciences Inc.
|
US
|
NASDAQ
|
|
MORF
|
Morphic Holding, Inc.
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PULM
|
Pulmatrix, Inc.
|
US
|
NASDAQ
|
|
RVPH
|
Reviva Pharmaceuticals Holdings, Inc.
|
US
|
NASDAQ
|
|
TRVI
|
Trevi Therapeutics, Inc.
|
US
|
NASDAQ
|
|
VCYT
|
Veracyte, Inc.
|
US
|
NASDAQ
|
|
1AD
|
Adalta Ltd
|
AU
|
ASX
|
|
ATX
|
Amplia Therapeutics Limited
|
AU
|
ASX
|
|
AGNPF
|
Algernon Pharmaceuticals Inc.
|
US
|
OTC
|
|
GLPGF
|
Galapagos Genomics Ord
|
US
|
OTC
|
|
SYGGF
|
Synairgen Plc
|
US
|
OTC
|
|
SNG
|
Synairgen Plc
|
UK
|
LSE
|
|
GLPG
|
Galapagos NV
|
NL
|
AS
|
|
0TB
|
Theravance Biopharma Inc
|
DE
|
F
|